Nanolive SA has developed a disruptive proprietary technology, which allows for the very first time to explore a living cell in 3D without damaging it.
Nanolive SA has developed a disruptive proprietary technology, which allows for the very first time to explore a living cell in 3D without damaging it. By experiencing the living cell in a completely new way, our 3D Cell-Explorer shows a comprehensive representation in color of its activity. Since the cell is the basis of all life on earth, this is a major milestone in the history of microscopy, which may change all the rules in the fields of education, biology, pharmaceutics, cosmetics, labs and industry. With our affordable 3D Cell-Explorer, never again will researchers have to “guess” what happens inside a living cell.
Nanolive has developed the 3D Cell-Explorer thanks to a proprietary and completely innovative technology, which overcomes the inherent limitation of light, and pushing it far beyond any physical limit we ever thought possible. Just like a computer tomography for human bodies, our product makes a complete tomography of the living cell. But unlike a CT for human bodies, it does it instantly, in full color and at very low cost: as a result, for the very first time users can instantly look inside the cell, discover its interior such as nucleus and organelles and "travel" through it in
3D on any screen, as well as compare it quantitatively with accumulated data (& processing) in the cloud.
The Cell-Explorer’s technology is unique worldwide and is based on a fundamental patent (US &
EU WO 2011/121523). It works in vitro without any invasion or sample preparation and the result is live-cell tomography in full color with even better resolution than traditional optical microscopy. In combination with the Cell-Explorer’s user-friendly interface and real- time processing time (~0.5
seconds), it is a perfect match for implementation in cell-based learning and decision-making.
Supplementary services will be available in the future through our Cloud Biotech Apps and
Communities, thus making the 3D Cell-Explorer the first cloud microscope.
We are 25-35yrs old first timers, and inventors (physicists & engineers) of our unique & proprietary technology. For the first time in History of Science, our 3D Cell-Explorer delivers living cell tomography. Our product uses laser light to make live scans of cells. The 3D Cell-Explorer performs a continuous rotational scan, and displays quasi instantaneously the cell in 3D and in colors on any device. Since our 3D Cell-Explorer does not require any special sample preparation
(no chemicals, no staining), and thanks to its straight forward handling (open access, compatible with many imaging conditions),the 3D Cell-Explorer will completely transform the Bio, Pharma,
Medcine and Cosmetic industry as we know it today.... starting with huge revenues from just educating the market.
Nanolive SA has filed 2 patents (fundamental WO/2011121523, product EP14185718.5) and currently 3 additional patents are under redaction. In addition, Trade Secret applies to both, all software related processing as well as hardware specific development related to the microscope’s self adjustment & maintenance features. Nanolive’s IP strategy is completed by several trademarks including registered brand, broad covey of www domains (>30), and registered design rights. On the long term strategy, we are preparing uncopyable technical features that are specific to Nanolive’s unique technological capacities, possibly reinforced by licensed patents
993295-nl_logo_positiv_a_200115.pdf
• Website:
www.nanolive.ch
• Activity: Biotech
• Contact:
COTTE Yann yann@nanolive.ch
• Location:
EPFL Innovation Park 1a
Chemin de la dent d'Oche
1024 Ecublens
Switzerland
• Founded in: 18/11/2013
• Employees: 9
• Management:
Cotte Yann
CEO
Equis Sebastien
CTO
• Financial information (€):
- Company stage:
at market entry
- Capital raised to date:
2.8
- Monthly burn rate:
50'000
- Capital seeking and date:
8 Mio in 2015
• Investors:
Prof. Dr. Thomas Steinmann,
Prof. Dr. Christian Depeuringe,
Dr. Federico Faggin,
Pierre-Alain Cotte, Dr. Mathurin
Baquie
• Referred by:
Philippe Pouletty